1d
Zacks.com on MSNCognizant (CTSH) is a Top-Ranked Momentum Stock: Should You Buy?It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read the latest updates from Cognizant, Commvault and BCN – as well as which company took home the Services Provider of the ...
TEANECK, N.J. (AP) — TEANECK, N.J. (AP) — Cognizant Technology Solutions Corp. (CTSH) on Wednesday reported fourth-quarter profit of $546 million. The Teaneck, New Jersey-based company said it had net ...
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Cognizant ...
TEANECK, N.J., Jan. 30, 2025 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD ...
Cognizant (Nasdaq: CTSH) announced an expanded agreement with Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, to provide support for ...
"Our partnership with Cognizant represents a shared commitment to transforming clinical research through innovation and expertise," said Janet Butler, EVP, Head of Global Sales, of Medidata.
The organizations plan to support clients through expanded partnership and offer broader access to Medidata's AI-powered technologies to accelerate clinical trial development TEANECK, N.J., Jan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results